Foresite Capital

Activity in this selectionFeb 28, 2026 · Feb 1, 2026

By stage

Series A2

Series C+1

Biotech2

Healthtech1

United States3

3 in this selection

Feb 24

Advancing next-generation therapeutics for migraine and other headache disorders

$130MSeries A

Role not disclosed

Feb 18

Develops novel therapies to reduce the burden of neurodegenerative diseases

$175MSeries A

Role not disclosed

Feb 3

Provides accessible, insurance-covered services in all 50 states for women's healthcare

$100MSeries D

Role not disclosed